BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6786151)

  • 1. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.
    Klein GL; Horst RL; Alfrey AC; Slatopolsky E
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):93-6. PubMed ID: 3920379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic bone disease associated with total parenteral nutrition.
    Klein GL; Coburn JW
    Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic bone disease in patients receiving long-term total parenteral nutrition.
    Shike M; Harrison JE; Sturtridge WC; Tam CS; Bobechko PE; Jones G; Murray TM; Jeejeebhoy KN
    Ann Intern Med; 1980 Mar; 92(3):343-50. PubMed ID: 6766694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.
    Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH
    Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D metabolism in hypophosphatemic rickets.
    Mason RS; Rohl PG; Lissner D; Posen S
    Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
    Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
    Chesney RW; Hamstra A; Rose P; DeLuca HF
    Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
    J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone disease associated with total parenteral nutrition.
    Klein GL; Targoff CM; Ament ME; Sherrard DJ; Bluestone R; Young JH; Norman AW; Coburn JW
    Lancet; 1980 Nov; 2(8203):1041-4. PubMed ID: 6107676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term.
    Fleischman AR; Rosen JF; Cole J; Smith CM; Deluca HF
    J Pediatr; 1980 Oct; 97(4):640-2. PubMed ID: 6968348
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children.
    Garabedian M; Silve C; Levy-Bentolila D; Bourdeau A; Ulmann A; Nguyen TM; Lieberherr M; Broyer M; Balsan S
    Kidney Int; 1981 Sep; 20(3):403-10. PubMed ID: 7029120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.
    Lambert PW; Stern PH; Avioli RC; Brackett NC; Turner RT; Greene A; Fu IY; Bell NH
    J Clin Invest; 1982 Mar; 69(3):722-5. PubMed ID: 6895901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in circulating 1,25-dihydroxyvitamin D during reproduction in rats.
    Pike JW; Parker JB; Haussler MR; Boass A; Toverud SV
    Science; 1979 Jun; 204(4400):1427-9. PubMed ID: 451573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.